(EMAILWIRE.COM, May 11, 2018 ) Browse 92 Market Data Tables and 39 Figures spread through 168 Pages and in-depth TOC on "Drug Discovery Services Market"
https://www.marketsandmarkets.com/Market-Reports/drug-discovery-services-market-138732129.html
Early buyers will receive 10% customization on this report.

The major factors driving the growth of this market are increasing research and development expenditure, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, and increasing demand for outsourcing of analytical testing and clinical trial services.

The drug discovery services market is fragmented in nature due to the presence of a large number of players. The key players are Thermo Fisher Scientific (US), Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories International, Inc. (US), Evotec (Germany), Domainex (UK), GenScript (US), Covance (US), Selcia (UK), Viva Biotech (China), WuXi AppTec (China), SRI International (US), Pharmaceutical Product Development, LLC (PPD) (US).

Other key players of the market are GVK Biosciences (India), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Lonza (Switzerland), Piramal Enterprises (India), Advinus Therapeutics (India), Promega Corporation (US), Syngene International (India), Aurigene (India), Agilent Technologies (US), Ubiquigent (UK), and ChemBridge Corporation (US).

Expansions, partnerships, agreements, and collaborations were the key strategies followed by players in the drug discovery services market. Some of the leading players that adopted this strategy include Charles River Laboratory (US), Evotec (Germany), Domainex (UK), GenScript (US), and Covance (US).

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=138732129

Covance accounted for the largest share of 20.2% of the drug discovery services market in 2016. The company has a broad product portfolio and caters to different therapeutic applications. Covance mainly focuses on organic strategies, such as product launches and expansions.

The company also focuses on inorganic strategies to strengthen its position in the market. For instance, in July 2017, LabCorp (the parent company of Covance) acquired Chiltern International Ltd. (UK) to expand its oncology service offerings.

Charles River Laboratories accounted for the second-largest share of 12.2% of the drug discovery services market in 2016. The company offers all services required during a drug discovery process. By combining its proprietary adenoviral technology with complex cellular assays, Charles River’s target discovery group has delivered novel, validated drug targets in a range of therapeutic areas.

The company focuses on organic and inorganic strategies to strengthen its position in the drug discovery services market. In 2015, the company collaborated with three innovative drug discovery partners funded by the Wellcome Trust to provide a comprehensive suite of in vitro and in vivo pharmacology, drug metabolism and pharmacokinetics (DMPK), and medicinal chemistry services.

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=138732129

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com